Á¸°æÇÏ´Â ´ëÇÑ¿Ü°úÃÊÀ½ÆÄÇÐȸ ȸ¿ø ¿©·¯ºÐ ¾È³çÇϽʴϱî?

2024³â ÇÑÇصµ ȸ¿ø ¿©·¯ºÐ °¡Á¤¿¡ °Ç°­°ú ÇູÀÌ ÇÔ²²ÇÏ½Ç º÷´Ï´Ù.

´ëÇÑ¿Ü°úÃÊÀ½ÆÄÇÐȸ´Â ¸Å³â ÃÖ½ÅÀÇ·á±â¼úÀ» ½ÀµæÇÏ°í Åä·ÐÇÒ ¼ö ÀÖ´Â ±âȸÀÇ ÀåÀ» ¸¶·ÃÇØ ¿À°í Àִµ¥ ¿ÃÇصµ ¡®2024 ÃÖ¼Òħ½ÀÀû À¯¹æ»ý°Ë ½ÉÆ÷Áö¾ö¡¯À» 2024³â 2¿ù 17ÀÏ(Åä) ¼­¿ï °­³² »ïÁ¤È£ÅÚ¿¡¼­ °³ÃÖÇÏ°Ô µÇ¾ú½À´Ï´Ù.


ƯÈ÷, À̹ø ½ÉÆ÷Áö¾ö¿¡¼­´Â À¯¹æ»ý°Ë(Mammotome)°ú °ü·ÃµÈ ¿©·¯°¡Áö »çÇ×µéÀ» ½ÉµµÀÖ°Ô ¹ßÇ¥ÇÏ°í Åä·ÐÇÏ´Â ½Ã°£À» °®°íÀÚ ÇÕ´Ï´Ù.

°­ÀÇ ³»¿ëÀ¸·Î´Â
Needle tract seeding after vacuum-assisted breast biopsy (Mammotome) ±èÁØÈ£(Á¶ÀºÀ¯¿Ü°ú), Can phyllodes tumor of breast be distinguished from fibroadenoma using core needle biopsy? ¹®¼ÒÇâ(¶ó¶óÀ¯¿Ü°ú), Benign proliferative breast disease with and without atypia on VABB ½ÅÀº¾Æ(¿ëÀμ¼ºê¶õ½º º´¸®°ú), Does Mammotome biopsy affect surgery option and margin status of breast conserving surgery in breast cancer? À̵¿¼®(ºÐÈ«ºûÀ¸·Îº´¿ø) ÀÌ ÁغñµÇ¾î ÀÖ½À´Ï´Ù.

¶ÇÇÑ VABBÀåºñ(Mammotome Revolve Ex)ÀÇ ¼Ò°³¿Í ÇÚÁî¿Âµµ ÁغñµÇ¾î ÀÖÀ¸´Ï °ü½ÉÀִ ȸ¿ø´ÔµéÀÇ Àû±ØÀûÀÎ Âü¿©¸¦ ±â´ëÇÕ´Ï´Ù.

¾Æ¹«ÂÉ·Ï ³»³» °Ç°­ÇϽðí 2¿ù 17ÀÏ¿¡ ºË°Ú½À´Ï´Ù


°¨»çÇÕ´Ï´Ù.



2024³â 1¿ù
´ëÇÑ¿Ü°úÃÊÀ½ÆÄÇÐȸ ȸÀå ±è Çü ö